cvot tirzepatide A comparison of the effects of and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial Post hoc analysis of SURPASS-CVOT

Youre doing greatthis is a step towards your health goals

When stopping weekly injections of the prescription drug, you may experience appetite changes, blood sugar issues, weight gain, and digestive upset

Below are the top agencies in 2026 helping weight loss and GLP1 telehealth brands scale successfully

Symptoms of both types include: Extreme hunger Increased thirst Frequent urination Unexplained weight loss or gain Fatigue and/or irritability Blurry vision Slow healing of cuts Frequent skin or vaginal infections Excess ketones in the urine (caused by the breakdown of fat and muscle when not enough insulin is produced) The hemoglobin A1C test is a blood test for diagnosing diabetes and monitoring blood sugar control after starting treatment